| scholarly article | Q13442814 |
| P5530 | Altmetric DOI | 10.1186/S40814-016-0046-2 |
| P6409 | CORE ID | 81700457 |
| P6179 | Dimensions Publication ID | 1034617349 |
| P356 | DOI | 10.1186/S40814-016-0046-2 |
| P953 | full work available at URL | http://eprints.whiterose.ac.uk/101994 |
| P932 | PMC publication ID | 5153694 |
| P698 | PubMed publication ID | 27965826 |
| P1154 | Scopus EID | 2-s2.0-84992162078 |
| P50 | author | Janine Bestall | Q42713074 |
| David Sebag-Montefiore | Q43195788 | ||
| Samantha Hinsley | Q59139774 | ||
| P2093 | author name string | C M Lowe | |
| D R Baldwin | |||
| B Naidu | |||
| A Striha | |||
| F Collinson | |||
| J Hewison | |||
| L McParland | |||
| M P Snee | |||
| W M Gregory | |||
| K Franks | |||
| P2860 | cites work | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 |
| 73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer | Q73395657 | ||
| Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis | Q33997877 | ||
| Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review | Q34121705 | ||
| The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population | Q34204947 | ||
| Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group | Q34721402 | ||
| Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials | Q37480195 | ||
| Radiation therapy for medically inoperable stage I and II non-small cell lung cancer | Q38330179 | ||
| Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit | Q39416355 | ||
| The Curative Treatment by Radiotherapy Alone of Stage I Non-Small Cell Carcinoma of the Lung | Q40431700 | ||
| Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies | Q41134625 | ||
| Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study | Q44561704 | ||
| Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types | Q46136233 | ||
| Video-assisted thoracic surgery lobectomy: experience with 1,100 cases | Q46787616 | ||
| Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. | Q53667358 | ||
| Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study | Q57192409 | ||
| P2507 | corrigendum / erratum | Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peri | Q42353451 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| phase III clinical trial | Q42824827 | ||
| P304 | page(s) | 5 | |
| P577 | publication date | 2016-02-01 | |
| P1433 | published in | Pilot and feasibility studies | Q27727225 |
| P1476 | title | The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection | |
| P478 | volume | 2 |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q61821586 | Are quality of life outcomes comparable following stereotactic radiotherapy and minimally invasive surgery for stage I lung cancer patients? |
| Q52763791 | Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study. |
| Q60908706 | Developments in Stereotactic Body Radiotherapy |
| Q42353451 | Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peri |
| Q37077160 | Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis |
| Q55392268 | Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey. |
| Q64276234 | Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis |
| Q90257623 | Premature Termination of a Randomized Controlled Trial on Image-Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord Compression |
| Q57172947 | Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances |
| Q57177641 | Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions |
| Q55062398 | Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions. |
| Q48369218 | Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. |
| Q58764285 | Surgical Resection Versus Stereotactic Body Radiation Therapy for Stage I NSCLC: Can Randomized Trials Provide the Solution? |
| Q90175125 | The evolving role of radiotherapy in non-small cell lung cancer |
| Q50138849 | The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer |
| Q64111832 | Three discipline collaborative radiation therapy (3 DCRT ) special debate: I would treat all early‐stage NSCLC patients with SBRT |
| Q47138383 | Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter? |
| Q92356100 | Verification of meta-analysis and propensity-matched analysis comparing stereotactic body radiation therapy versus surgery for early stage lung cancer |
| Q92467682 | Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate |
| Q42353451 | Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peri | main subject | P921 |